EMPA-REG Outcome Trial Results

Document ID: VV_103548

06/12/2018

Author: Boehringer Ingelheim


Demonstrating cardioprotection with jardiance by reducing the risk of CV death on top of standard of care

123,000
Views

100k 340


Production date: Dec 2018